Clinical trial
Open-labeled, Multicenter, Phase I/II Study of Imatinib Combined With ESHAP as Salvage Therapy in Relapsed/Refractory Non-Hodgkin's Lymphoma
NCT02431403 is registered in ClinicalTrials.gov with Pusan National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-labeled, Multicenter, Phase I/II Study of Imatinib Combined With ESHAP as Salvage Therapy in Relapsed/Refractory Non-Hodgkin's Lymphoma
- Lead sponsor
- Pusan National University Hospital
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- February 28, 2015
- Completion date
- Not reported
- Enrollment
- 94 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.